BinDawood Holding announced on Tuesday, February 18 the completion of its acquisition of 100% of Zahrat Al Rawdah Pharmacies, finalizing the regulatory procedures for share transfer and the notarization of the amended incorporation contract.
The company confirmed that the financial settlement will be executed as per the terms of the sale and purchase agreement.
In a statement on Tadawul, BinDawood revealed that the total acquisition value amounted to SAR 441.1 million, with the transaction amount adjusted in line with the agreement.
BinDawood expects this acquisition to have a positive long-term financial impact and considers it aligned with its strategic vision to expand in the healthcare sector.
